Introduction

The pharmaceutical industry is undergoing a transformative shift where Real-World Evidence (RWE) has become a cornerstone for drug development, regulatory decision-making, and market access strategies. RWE leverages data from electronic health records (EHRs), patient registries, claims databases, and wearables to provide insights into treatment effectiveness, safety profiles, and patient outcomes outside controlled clinical trials. By integrating data-driven analytics, predictive modeling, and health economics, RWE enables pharma companies to make evidence-based decisions that optimize clinical trials, accelerate approvals, and enhance patient-centric care.

Real-World Evidence (RWE) in Pharma Training Course is designed to equip professionals with practical skills, advanced analytical techniques, and regulatory knowledge required to implement RWE in pharmaceutical development. Participants will explore methodologies, data sources, statistical frameworks, and case studies demonstrating real-world applications. The program emphasizes strategic insights, regulatory compliance, and commercialization opportunities, ensuring learners gain actionable expertise that drives innovation, patient engagement, and healthcare outcomes in a competitive pharma landscape.

Programme Curriculum

Real-World Evidence (RWE) in Pharma Training Course

Introduction

Course Duration

5 days

Course Objectives

Understand the fundamentals of RWE and its role in pharma.
Explore RWE data sources: EHRs, claims, registries, and digital health.
Apply statistical and analytical methods for real-world data (RWD).
Integrate health economics and outcomes research (HEOR) in decision-making.
Evaluate regulatory frameworks for RWE submission.
Leverage predictive modeling and AI/ML in RWE studies.
Design RWE studies for post-marketing surveillance and safety monitoring.
Optimize patient recruitment and retention using real-world insights.
Implement data governance, quality, and privacy best practices.
Conduct comparative effectiveness research (CER) for treatment outcomes.
Translate RWE into market access and reimbursement strategies.
Interpret case studies of successful RWE implementation in pharma.
Develop actionable insights for stakeholder communication and decision-making.

Target Audience

Clinical researchers and trial managers
Pharmacovigilance and safety specialists
Health economics and outcomes research (HEOR) professionals
Regulatory affairs professionals
Market access and commercial strategy teams
Data scientists and biostatisticians
Medical affairs and clinical operations professionals
Pharmaceutical consultants and policy advisors

Course Modules

Module 1: Introduction to Real-World Evidence (RWE)

Definition and evolution of RWE in pharma
Difference between RWE and randomized clinical trials (RCTs)
Regulatory landscape and guidelines
Key use cases across drug lifecycle
Case Study: FDA approval of a drug using RWE

Module 2: Data Sources for RWE

Electronic Health Records (EHRs) and claims databases
Patient registries and disease-specific datasets
Wearables, mobile health apps, and digital biomarkers
Data integration and interoperability challenges
Case Study: Multi-source RWD integration for oncology outcomes

Module 3: Study Design & Methodologies

Observational studies: cohort, case-control, and cross-sectional
Pragmatic clinical trials and hybrid designs
Statistical methods for bias reduction
Handling missing data and confounders
Case Study: Real-world study on diabetes medication effectiveness

Module 4: Data Analytics and Artificial Intelligence

Predictive modeling and machine learning in RWE
Natural language processing for unstructured data
Data visualization and interpretation techniques
Risk stratification and patient segmentation
Case Study: AI-driven RWE for cardiovascular drug safety

Module 5: Health Economics & Outcomes Research (HEOR)

Cost-effectiveness and budget impact analysis
Quality-adjusted life years (QALY) and patient-reported outcomes
Comparative effectiveness research (CER)
Integration of RWE in payer and formulary decisions
Case Study: HEOR-driven reimbursement strategy in oncology

Module 6: Regulatory & Compliance Considerations

FDA, EMA, and other global regulatory frameworks
Guidelines for RWE submission and post-marketing studies
Privacy laws: HIPAA, GDPR, and ethical considerations
Risk management and audit readiness
Case Study: Regulatory approval of a rare disease therapy using RWE

Module 7: Commercialization & Market Access

Translating RWE into pricing and reimbursement strategies
Stakeholder engagement: payers, physicians, and patients
Real-world evidence in product lifecycle management
Strategic insights for market differentiation
Case Study: RWE-driven market access strategy in immunotherapy

Module 8: Implementation & Future Trends

Best practices for RWE project execution
Data governance and quality assurance
Emerging trends: decentralized trials, blockchain, and digital twins
Future opportunities for AI-enabled RWE
Case Study: Integration of RWE in digital therapeutics adoption

Training Methodology

This course employs a participatory and hands-on approach to ensure practical learning, including:

Interactive lectures and presentations.
Group discussions and brainstorming sessions.
Hands-on exercises using real-world datasets.
Role-playing and scenario-based simulations.
Analysis of case studies to bridge theory and practice.
Peer-to-peer learning and networking.
Expert-led Q&A sessions.
Continuous feedback and personalized guidance.

Register as a group from 3 participants for a Discount

Send us an email: info@fineskilltrainingcenter.org or call +254769199797

Certification

Upon successful completion of this training, participants will be issued with a globally- recognized certificate.

Tailor-Made Course

We also offer tailor-made courses based on your needs.

Key Notes

a. The participant must be conversant with English.

b. Upon completion of training the participant will be issued with an Authorized Training Certificate

c. Course duration is flexible and the contents can be modified to fit any number of days.

d. The course fee includes facilitation training materials, 2 coffee breaks, buffet lunch and A Certificate upon successful completion of Training.

e. One-year post-training support Consultation and Coaching provided after the course.

f. Payment should be done at least a week before commence of the training, to Fineskill Training Center account, as indicated in the invoice so as to enable us prepare better for you.

Skills & Software Covered

Data integration Outcome analysis Evidence generation Decision support

Programme Fee

Duration: 5 Days

Method: Online or Physical

Online Price: $1,000

Physical Price: $1,500

Certification: Accredited Certificate

View Available Dates 📄 Download Course Outline (PDF)

Available Sessions

Location

Month

Year

Oct 19 2026

19 Oct — 23 Oct 2026

💻 Online / Virtual session

Online $1,000